We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




AI-Powered Method Combines Blood Data to Accurately Measure Biological Age

By LabMedica International staff writers
Posted on 30 Oct 2025

Chronological age tells us how many years we’ve lived, but not how quickly our bodies are ageing. More...

Some people stay healthy well into their 80s or 90s, while others experience decline much earlier. To bridge this gap, researchers have developed a new biological age measurement tool that uses artificial intelligence (AI) to identify how fast the body is truly ageing — potentially helping doctors detect and track age-related diseases sooner.

In a study led by Edith Cowan University (Perth, WA, Australia) in collaboration with Royal Prince Alfred Hospital (Sydney, NSW, Australia) and Shantou University Medical College (Shantou, Guangdong, China), the research team studied two key biological datasets from blood samples. The first was the IgG N-glycome, which represents sugar structures attached to antibodies, and the second was the transcriptome, which provides a snapshot of gene activity within blood cells.

By integrating these datasets through an AI technique known as Deep Reinforcement Learning, the researchers developed a new ageing clock called gtAge. The gtAge model accurately predicted a person’s age with 85% precision, outperforming models that relied on only one type of data. The researchers also found that the difference between predicted biological age and actual chronological age — known as delta age — correlated strongly with health markers such as cholesterol and blood glucose levels, which are linked to ageing and metabolic diseases.

To achieve this breakthrough, the team created a custom AI framework named AlphaSnake, designed to improve prediction accuracy by selectively identifying the most relevant data points from the two biological sources. Unlike conventional models that blend data without discrimination, AlphaSnake uses Deep Reinforcement Learning to identify the optimal features that contribute to ageing, resulting in a more refined and biologically meaningful model.

The study tested gtAge on 302 middle-aged adults from the Busselton Healthy Ageing Study in Western Australia. The researchers concluded that measuring biological age instead of chronological age could provide valuable insights into a person’s health trajectory. The tool could eventually be used to guide lifestyle or medical interventions aimed at slowing biological ageing and preventing chronic disease.

“By merging IgG N-glycome data and transcriptome data, we have elevated the accuracy of biological ageing estimation,” said Dr. Xingang Li, Postdoctoral Research Fellow at ECU’s School of Medical and Health Sciences. “It links to real health risks and could help spot people at risk of age-related diseases earlier.”

Related Links:
ECU
Royal Prince Alfred Hospital
Shantou University Medical College


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image Credit: iStock

Global TB Summit Connects Diagnostic Testing With Prevention and Clinical Care

Tuberculosis remains a major global infectious disease challenge despite declining deaths. In 2024, an estimated 10.7 million people worldwide developed the disease and nearly 1.2 million died from it.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.